MeSH Review:
Leishmania
- IL-13 effector functions. Wynn, T.A. Annu. Rev. Immunol. (2003)
- Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Kamhawi, S., Belkaid, Y., Modi, G., Rowton, E., Sacks, D. Science (2000)
- A common major surface antigen on amastigotes and promastigotes of Leishmania species. Colomer-Gould, V., Glvao Quintao, L., Keithly, J., Nogueira, N. J. Exp. Med. (1985)
- Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. Cellier, M., Govoni, G., Vidal, S., Kwan, T., Groulx, N., Liu, J., Sanchez, F., Skamene, E., Schurr, E., Gros, P. J. Exp. Med. (1994)
- Interferon gamma signaling alters the function of T helper type 1 cells. Tau, G.Z., von der Weid, T., Lu, B., Cowan, S., Kvatyuk, M., Pernis, A., Cattoretti, G., Braunstein, N.S., Coffman, R.L., Rothman, P.B. J. Exp. Med. (2000)
- The relationship of American visceral leishmaniasis to ABO blood group type. Evans, T., Naidu, T.G., de Alencar, J.E., Pearson, R.D. Am. J. Trop. Med. Hyg. (1984)
- Flypaper for parasites. Beverley, S.M., Dobson, D.E. Cell (2004)
- Unstable DNA amplifications in methotrexate-resistant Leishmania consist of extrachromosomal circles which relocalize during stabilization. Beverley, S.M., Coderre, J.A., Santi, D.V., Schimke, R.T. Cell (1984)
- Kinetoplast RNA of Leishmania tarentolae. Simpson, L., Simpson, A.G. Cell (1978)
- Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Mathur, R.K., Awasthi, A., Wadhone, P., Ramanamurthy, B., Saha, B. Nat. Med. (2004)
- Hydrogen peroxide-mediated toxicity for Leishmania donovani chagasi promastigotes. Role of hydroxyl radical and protection by heat shock. Zarley, J.H., Britigan, B.E., Wilson, M.E. J. Clin. Invest. (1991)
- Nodular lymphangitis: a distinctive but often unrecognized syndrome. Kostman, J.R., DiNubile, M.J. Ann. Intern. Med. (1993)
- Biochemical genetic analysis of formycin B action in Leishmania donovani. Robinson, N., Kaur, K., Emmett, K., Iovannisci, D.M., Ullman, B. J. Biol. Chem. (1984)
- Methotrexate-resistant Leishmania donovani genetically deficient in the folate-methotrexate transporter. Kaur, K., Coons, T., Emmett, K., Ullman, B. J. Biol. Chem. (1988)
- The effect of BCG on experimental cutaneous leishmaniasis in mice. Weintraub, J., Weinbaum, F.I. J. Immunol. (1977)
- Control of tubulin gene expression in the parasitic protozoan Leishmania enriettii. Landfear, S.M., Wirth, D.F. Nature (1984)
- Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Güler, M.L., Gorham, J.D., Hsieh, C.S., Mackey, A.J., Steen, R.G., Dietrich, W.F., Murphy, K.M. Science (1996)
- Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. Campos-Neto, A., Soong, L., Cordova, J.L., Sant'Angelo, D., Skeiky, Y.A., Ruddle, N.H., Reed, S.G., Janeway, C., McMahon-Pratt, D. J. Exp. Med. (1995)
- CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. Sato, N., Ahuja, S.K., Quinones, M., Kostecki, V., Reddick, R.L., Melby, P.C., Kuziel, W.A., Ahuja, S.S. J. Exp. Med. (2000)
- Immune adherence-mediated opsonophagocytosis: the mechanism of Leishmania infection. Domínguez, M., Toraño, A. J. Exp. Med. (1999)
- Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. Murray, H.W., Rubin, B.Y., Rothermel, C.D. J. Clin. Invest. (1983)
- Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1. Reiner, N.E., Ng, W., Wilson, C.B., McMaster, W.R., Burchett, S.K. J. Clin. Invest. (1990)
- Rab5-mediated endosome-endosome fusion regulates hemoglobin endocytosis in Leishmania donovani. Singh, S.B., Tandon, R., Krishnamurthy, G., Vikram, R., Sharma, N., Basu, S.K., Mukhopadhyay, A. EMBO J. (2003)
- Stable expression of the bacterial neor gene in Leishmania enriettii. Laban, A., Tobin, J.F., Curotto de Lafaille, M.A., Wirth, D.F. Nature (1990)
- Differential inhibition by erythro-9-[3-(2-hydroxynonyl)]adenine of flagella-like and cilia-like movement of Leishmania promastigotes. Alexander, J., Burns, R.G. Nature (1983)
- Inhibition of leishmanias but not host macrophages by the antitubulin herbicide trifluralin. Chan, M.M., Fong, D. Science (1990)
- Lethal effect of phenothiazine neuroleptics on the pathogenic protozoan Leishmania donovani. Pearson, R.D., Manian, A.A., Harcus, J.L., Hall, D., Hewlett, E.L. Science (1982)
- Fluorogenic substrate detection of viable intracellular and extracellular pathogenic protozoa. Jackson, P.R., Pappas, M.G., Hansen, B.D. Science (1985)
- Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Lipoldová, M., Demant, P. Nat. Rev. Genet. (2006)
- Distinct genetic control of parasite elimination, dissemination, and disease after Leishmania major infection. Kurey, I., Kobets, T., Havelková, H., Slapnicková, M., Quan, L., Trtková, K., Grekov, I., Svobodová, M., Stassen, A.P., Hutson, A., Demant, P., Lipoldová, M. Immunogenetics. (2009)
- Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Soong, L., Xu, J.C., Grewal, I.S., Kima, P., Sun, J., Longley,, B.J., Ruddle, N.H., McMahon-Pratt, D., Flavell, R.A. Immunity (1996)
- Deletion of a conserved Il4 silencer impairs T helper type 1-mediated immunity. Ansel, K.M., Greenwald, R.J., Agarwal, S., Bassing, C.H., Monticelli, S., Interlandi, J., Djuretic, I.M., Lee, D.U., Sharpe, A.H., Alt, F.W., Rao, A. Nat. Immunol. (2004)
- CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. Wang, Z.E., Reiner, S.L., Zheng, S., Dalton, D.K., Locksley, R.M. J. Exp. Med. (1994)
- Interleukin 10 production correlates with pathology in human Leishmania donovani infections. Ghalib, H.W., Piuvezam, M.R., Skeiky, Y.A., Siddig, M., Hashim, F.A., el-Hassan, A.M., Russo, D.M., Reed, S.G. J. Clin. Invest. (1993)
- Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Ato, M., Stäger, S., Engwerda, C.R., Kaye, P.M. Nat. Immunol. (2002)
- Molecular cloning and characterization of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis. Lohman, K.L., Langer, P.J., McMahon-Pratt, D. Proc. Natl. Acad. Sci. U.S.A. (1990)
- A trypanothione-dependent glyoxalase I with a prokaryotic ancestry in Leishmania major. Vickers, T.J., Greig, N., Fairlamb, A.H. Proc. Natl. Acad. Sci. U.S.A. (2004)
- PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major. Bello, A.R., Nare, B., Freedman, D., Hardy, L., Beverley, S.M. Proc. Natl. Acad. Sci. U.S.A. (1994)